-+ 0.00%
-+ 0.00%
-+ 0.00%

Enanta Pharma Q4 EPS $(0.87) Beats $(1.03) Estimate, Sales $15.125M Miss $15.956M Estimate

Benzinga·11/17/2025 21:02:30
Listen to the news
Enanta Pharma (NASDAQ:ENTA) reported quarterly losses of $(0.87) per share which beat the analyst consensus estimate of $(1.03) by 15.29 percent. This is a 36.03 percent increase over losses of $(1.36) per share from the same period last year. The company reported quarterly sales of $15.125 million which missed the analyst consensus estimate of $15.956 million by 5.21 percent. This is a 3.55 percent increase over sales of $14.607 million the same period last year.